Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-29
2007-05-29
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S578000, C514S725000, C514S730000, C514S739000, C424S523000, C426S072000, C426S601000, C426S602000, C426S656000, C426S800000, C426S801000
Reexamination Certificate
active
10784451
ABSTRACT:
The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of ω-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.
REFERENCES:
patent: 4526902 (1985-07-01), Rubin
patent: 4977187 (1990-12-01), Horrobin
patent: 5053387 (1991-10-01), Alexander
patent: 5223285 (1993-06-01), DeMichele et al.
patent: 5308832 (1994-05-01), Garleb et al.
patent: 5326569 (1994-07-01), Acosta
patent: 5385740 (1995-01-01), Tisdale et al.
patent: 5393784 (1995-02-01), Richarson
patent: 5431925 (1995-07-01), Ohmori et al.
patent: 5444054 (1995-08-01), Garleb et al.
patent: 5457130 (1995-10-01), Tisdale
patent: 5599835 (1997-02-01), Fischer
patent: 5776913 (1998-07-01), Ogilvie
patent: 0367724 (1990-05-01), None
patent: 0462398 (1991-12-01), None
patent: 0756827 (1996-02-01), None
patent: WO 95/08349 (1995-03-01), None
patent: WO 97/13415 (1997-04-01), None
Blot, et al., “Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General Population”, Journal of the National Cancer Institute, vol. 85, No. 18, Sep. 15, 1993.
Li, et al., “Nutrition Intervention Trials in Linxian, China: Multiple Vitamin/Mineral Supplementation, Cancer Incidence, and Disease-Specific Mortality Among Adults With Esophageal Dysplasia”, Journal of the National Cancer Institute, vol. 85, No. 18, Sep. 15, 1993.
Abstract of Japanese Patent Application No. 5-335311.
Abstract of Japanese Patent Application No. 6-51064.
Abstract of Japanese Patent Application No. 1-282844.
DeRham, “Nitrogen content of proteins . . . ” CA 97:143230 (1982).
Shellock, et al., “Brown adipose tissue in cancer patients . . . ” MEDLINE 86140335 (1986).
DeMichele, et al., “Enhanced skeletal muscle and . . . ” MEDLINE 88301889 (1988).
Gollaher, et al., “The effect of increasing levels of fish oil . . . ” MEDLINE 93280824 (1993).
Henderson, Robin A., et al., Effect of Fish Oil on the Fatty Acid Composition of Human Milk and Maternal and Infant Erythroytes, LIPIDS, vol. 27, No. 11 (1992), pp. 863-869.
Tisdale, Michael J., et al., Inhibition of Weight Loss by ω-3 Fatty Acids in an Experimental Cachexia Model, Cancer Research 50, 5022-5026, Aug. 15, 1990.
Dinarello, Charles A., et al., Interleukin-1, Anorexia, and Dietary Fatty Acids, Annals of the New York Academy of Sciences, vol. 587, pp. 332-338.
Build Bulk and Muscle for that Competitive Edge, Herbalife Advertisement, Los Angeles, California, 90080-00210, 1996.
Cangiano, C., et al., Plasma and CSF Tryptophan in Cancer Anorexia, J Neural Transm (GenSect) 1990, 81:225-223.
Rossi-Fanelli, F., M.D., et al., Increased Availability of Tryptophan in Brain as Common Pathogenic Mechanism for Anorexia Associated with Different Diseases, NUTRITION, vol. 7 No. 5, Sep./Oct. 1991.
Ottery, Faith D., M.D., Supportive Nutrition to Prevent Cachexia and Improve Quality of Life, Seminars in Oncology, vol. 22, No. 2, Supplement 3 (Apr.), 1995, pp. 98-111.
Kern, Kenneth, M.D., et al., Cancer Cachexia, Journal of Parental and Enteral Nutrition, vol. 12, No. 3, pp. 286-294 (1988).
Heber, David, M.D., Ph.D., et al., Hormonal and Metabolic Abornalities in the Malnourished Cancer Patient; Effects on Host-Tumor Interaction, Journal of Parenteral and Enteral Nutrition, vol. 16, No. 6, Supplement, pp. 60S-64S (1992).
McNamara, Michael J., M.D., et al. Cytokines and Their Role in the Pathophysiology of Cancer Cachexia, Journal of Parenteral and Enteral Nutrition, vol. 16, No. 6, Supplement, pp. 50S-55S (1992).
Tisdale, M.J., Cancer Cachexia, Anti Cancer Drugs, vol. 4, pp. 113-125 (1993).
Bozzetti, Federico, M.D., Effects of Artificial Nutrition on the Nutritional Status of Cancer Patients, Journal of Parenteral and Enteral Nutrition, vol. 13, No. 4 pp. 406-420 (1989).
Derwent—011043748.
Derwent—011043746.
Derwent—008405601.
Todorov, Penio, et al., Characterization of a cancer cachectic factor, NATURE, vol. 379, Feb. 22, 1996, pp. 739-742.
Wigmore, Stephen, et al., The Effect of Polyunsaturated Fatty Acids on the Progress of Cachexia in Patients With Pancreatic Cancer, NUTRITION, vol. 12, No. 1, 1996, pp. S27-S30.
Keller, Ulrich, Pathophysiology of cancer cachexia, Supportive Care in Cancer (1993) 1:209-294.
Derwent—90-225190.
Derwent—Abstract 010905121.
Ottery, Faith D., M.D. Cancer Cachexia, Cancer Practice, Mar./Apr. 1994, vol. 2, No. 2, pp. 123-131.
Rossi-Fanelli, Filippo, et al., Plasma Tryptophan and Anorexia in Human Cancer, Eur J Cancer Clin Oncol, vol. 22, No. 1 pp. 89-95, 1986.
Krause, Rudolf, et al., Brain Tryptophan and the Neoplastic Anorexia-Cachexia Syndrome, CANCER, Sep. 1979, 44: pp. 1003-1008.
Meguid, Michael, et al., The Early Cancer Anorexia Paradigm: Changes in Plasma Free Tryptophan and Feeding Indexes, Journal of Parenteral and Enteral Nutrition, vol. 16, No. 6, Supplement, pp. 56S-59S.
Abstract of DE 39010048.
Derwent 008338139.
Impact® with Fiber (1992 Clinical Products Division, Sandoz Nutrition Corporation).
Impact® (Jun. 1995 Ross Products Division, Abbott Laboratories).
Impact® with Fiber (1992 product sheet).
Cangiano, et al., “Cytokines, Tryptophan and Anorexia in Cancer Patients before and after Surgical Tumor Ablation”, Anticancer Research 14: 1451-1456 (1994).
Abbruzzese Bonnie Chandler
Cope Frederick Oliver
DeMichele Stephen Joseph
McCamish Mark Anthony
Abbott Laboratories
Brainard Thomas D.
Chang Celia
Winter William J.
LandOfFree
Composition for the prevention and treatment of cachexia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for the prevention and treatment of cachexia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the prevention and treatment of cachexia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3728750